CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT
Heart disease is the leading cause of mortality and one of the main causes of morbidity in beta-thalassemia. Patients with homozygous thalassemia may have either a severe phenotype which is usually transfusion dependent or a milder form that is thalassemia intermedia. The two main factors that dete...
Saved in:
| Main Authors: | Athanasios Aessopos, Vasilios Berdoukas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2009-07-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PREGNANCY IN THALASSEMIA
by: Raffaella Origa, et al.
Published: (2019-02-01) -
THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN
by: Sara Matin, et al.
Published: (2014-08-01) -
Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01) -
Cognitive performance, mental health, and quality of life in β-thalassemia individuals: a comprehensive analysis
by: Khaled Elbeh, et al.
Published: (2024-10-01) -
IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)